Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

NuviaRx vs telos rx

NuviaRx
Graded #69

Lower grade

vs+11.900000000000006
telos rx
Graded #9

Higher grade

The verdict

telos rx takes it — 85.4/100 to 73.5/100.

telos rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A LegitScript-certified, HIPAA telehealth with one of the deepest published catalogs on the board — compounded semaglutide and tirzepatide (oral and microdosed routes included) alongside PT-141, intranasal NAD+, and a long recovery/GH peptide bench — with compounded GLP-1 starting from $49/mo on an annual plan.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
87
87
Dose & formulationtelos rx +18
72
90
Clinical oversighttelos rx +2
82
84
Labs & monitoringtelos rx +27
53
80
Fulfillmenttelos rx +15
72
87
Contract termstelos rx +25
55
80
NuviaRx · left bartelos rx · right bar

The numbers

MetricNuviaRxtelos rx
WeighScore73.5/10085.4/100
GradeCB
Scorecard rank#69#9
Semaglutide$140/mo (all doses, compounded)From $49/mo (annual)
Tirzepatide$170/mo (all doses, compounded)$99/mo (annual)
CoverageCoverage not publishedNot publicly listed
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
NuviaRx

Graded #69 · C

Strengths

  • Transparent, affordable pricing — compounded semaglutide from $140/mo, tirzepatide from $170/mo
  • Free delivery included; clinical evaluation and prescription bundled (if eligible)
  • Full legal suite published (Terms, Privacy, HIPAA Notice, Informed Consent, Medical Disclaimer)
  • Named operating entity (NuviaRx Health Inc.) with a US address and phone support

Where it loses points

  • Compounding pharmacy partner not named ('partner pharmacy')
  • Not LegitScript-certified (no certification displayed)
  • Lowest pricing is 'as low as' — likely requires a longer prepaid plan
  • State availability not published
telos rx

Graded #9 · B

Strengths

  • Deep published catalog — sema, tirz, PT-141, intranasal NAD+, recovery/GH peptides, GHK-Cu, Dihexa, HRT
  • Needle-free and oral GLP-1 options, not injection-only
  • LegitScript-certified and HIPAA, with US providers and pharmacies, HSA/FSA and free shipping
  • Low GLP-1 entry — from $49/mo microdosed on an annual plan

Where it loses points

  • Everything is compounded and not FDA-approved, including the peptides
  • Pricing is opaque outside GLP-1 and the lowest rates require annual lock-in
  • No named clinicians and thin third-party reviews
  • Several research-grade peptides carry limited clinical evidence

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard